β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action

Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001

Ali H. Mokdad, Earl S. Ford, Barbara A. Bowman et al. · JAMA · 2003 · 5.9K citations

A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

Hiroaki Masuzaki, J. Paterson, Hiroshi Shinyama et al. · Science · 2001 · 1.8K citations

Obesity, Metabolic Syndrome, Health Sciences +14

Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice

Nicholas M. Morton, Janice M. Paterson, Hiroaki Masuzaki et al. · Diabetes · 2004 · 497 citations · Full text

Novel Adipose, Metabolic Disorder, Glucocorticoid +18

Metabolic syndrome without obesity: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice

Janice M. Paterson, Nicholas M. Morton, Catherine Fiévet et al. · Proceedings of the National Academy of Sciences · 2004 · 429 citations · Full text

Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2

Yuri Kotelevtsev, Roger Brown, Stewart Fleming et al. · Journal of Clinical Investigation · 1999 · 281 citations · Full text